Preliminary Analysis of B- and T-Cell Responses to SARS-CoV-2
Detection Principle
ImmunoAssay-Antibody
Target
IgM, IgG
Testing Method Category
Mixed
Testing Method
LFIA and MCLIA
Testing Method - Additional Info
LFIA and MCLIA, were supplied by Beier Bioengineering Co. Ltd (Beijing, China)
Reported Performance
sensitivity: 94.48% (LFIA-IgM), 95.28% (LFIA-IgG), 92.13% (MCLIA-IgM), 90.55% (MCLIA-IgG); specificity: 100% (LFIA-IgM), 100% (LFIA-IgG), 100% (MCLIA-IgM), 100% (MCLIA-IgG)
Sample Size
129 patients
Peer-reviewed
yes
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements